BIOMAT Database Logo BIOMAT Database Logo

[Determination of autoantibodies to pancreatic beta-cells, non-islet endocrine cells and fibroblasts in patients with newly detected diabetes mellitus]. 1993

O M Smirnova, and L A Chugunova, and E N Zlobina, and S V Brykova, and Iu M Keda, and I V Kriukova, and Iu A Pankov, and V I Kandror, and M I Arbuzova, and I I Dedov

The clinical onset of insulin-dependent diabetes (IDD) is characterized by the onset of circulation of autoantibodies to beta-cells. Thirty-three newly detected IDD patients and 14 newly detected patients with noninsulin-dependent diabetes mellitus were examined for autoantibodies to antigen P 64-69, to surface antigen of islet cells, to thyrocyte microsomal fraction, thyroglobulin, hypophysis, fibroblasts; the levels of circulating immune complexes were measured as well. IDD debut was found associated with the appearance of antibodies to pancreatic islet cells, thyroid, thyroglobulin, hypophysis, fibroblasts, this indicating a polyclonal activation of the immunity system. A relationship was revealed between antifibroblast antibody and anti-islet-cell antibody. Antihypophyseal antibodies were detected in 43% of patients with noninsulin dependent diabetes. Nine per cent of IDD patients and 24% of patients with noninsulin dependent condition were negative in the tests.

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010902 Pituitary Gland A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM. Hypophysis,Hypothalamus, Infundibular,Infundibular Stalk,Infundibular Stem,Infundibulum (Hypophysis),Infundibulum, Hypophyseal,Pituitary Stalk,Hypophyseal Infundibulum,Hypophyseal Stalk,Hypophysis Cerebri,Infundibulum,Cerebri, Hypophysis,Cerebrus, Hypophysis,Gland, Pituitary,Glands, Pituitary,Hypophyseal Stalks,Hypophyses,Hypophysis Cerebrus,Infundibular Hypothalamus,Infundibular Stalks,Infundibulums,Pituitary Glands,Pituitary Stalks,Stalk, Hypophyseal,Stalk, Infundibular,Stalks, Hypophyseal,Stalks, Infundibular
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

O M Smirnova, and L A Chugunova, and E N Zlobina, and S V Brykova, and Iu M Keda, and I V Kriukova, and Iu A Pankov, and V I Kandror, and M I Arbuzova, and I I Dedov
Autoantibodies to pancreatic islet cells in canine diabetes mellitus.
January 1985, Veterinary immunology and immunopathology,
O M Smirnova, and L A Chugunova, and E N Zlobina, and S V Brykova, and Iu M Keda, and I V Kriukova, and Iu A Pankov, and V I Kandror, and M I Arbuzova, and I I Dedov
[Autoantibodies to the pancreatic islet cells in type-1 diabetes mellitus].
January 1988, Sovetskaia meditsina,
O M Smirnova, and L A Chugunova, and E N Zlobina, and S V Brykova, and Iu M Keda, and I V Kriukova, and Iu A Pankov, and V I Kandror, and M I Arbuzova, and I I Dedov
Autoantibodies to islet cells in diabetes mellitus.
February 1979, Diabetes,
O M Smirnova, and L A Chugunova, and E N Zlobina, and S V Brykova, and Iu M Keda, and I V Kriukova, and Iu A Pankov, and V I Kandror, and M I Arbuzova, and I I Dedov
[Pancreatic hormone secretion in patients with newly detected diabetes mellitus].
January 1988, Problemy endokrinologii,
O M Smirnova, and L A Chugunova, and E N Zlobina, and S V Brykova, and Iu M Keda, and I V Kriukova, and Iu A Pankov, and V I Kandror, and M I Arbuzova, and I I Dedov
[Pancreatic function in newly detected diabetes mellitus].
January 1978, Terapevticheskii arkhiv,
O M Smirnova, and L A Chugunova, and E N Zlobina, and S V Brykova, and Iu M Keda, and I V Kriukova, and Iu A Pankov, and V I Kandror, and M I Arbuzova, and I I Dedov
Autoantibodies against insulin and beta-islet cells in pancreatic adenocarcinoma: a possible explanation for diabetes mellitus.
May 1996, International journal of cancer,
O M Smirnova, and L A Chugunova, and E N Zlobina, and S V Brykova, and Iu M Keda, and I V Kriukova, and Iu A Pankov, and V I Kandror, and M I Arbuzova, and I I Dedov
[Autoantibodies to glutamate decarboxylase in children with newly detected insulin-dependent diabetes mellitus].
January 1994, Problemy endokrinologii,
O M Smirnova, and L A Chugunova, and E N Zlobina, and S V Brykova, and Iu M Keda, and I V Kriukova, and Iu A Pankov, and V I Kandror, and M I Arbuzova, and I I Dedov
Islet Autoantibodies to Pancreatic Insulin-Producing Beta Cells in Adolescent and Adults with Type 1 Diabetes Mellitus: A Cross-Sectional Study.
May 2023, Diagnostics (Basel, Switzerland),
O M Smirnova, and L A Chugunova, and E N Zlobina, and S V Brykova, and Iu M Keda, and I V Kriukova, and Iu A Pankov, and V I Kandror, and M I Arbuzova, and I I Dedov
Low prevalence of islet autoantibodies in patients with gestational diabetes mellitus.
January 1997, Diabetes care,
O M Smirnova, and L A Chugunova, and E N Zlobina, and S V Brykova, and Iu M Keda, and I V Kriukova, and Iu A Pankov, and V I Kandror, and M I Arbuzova, and I I Dedov
[Differential treatment of patients with newly detected diabetes mellitus].
October 1985, Vrachebnoe delo,
Copied contents to your clipboard!